Cite
Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.
MLA
Mansoor, Leila E., et al. “Assessing the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision through Family Planning Services in KwaZulu-Natal, South Africa: Study Protocol for an Open-Label Randomized Controlled Trial.” Trials, vol. 15, no. 1, Dec. 2014, pp. 360–79. EBSCOhost, https://doi.org/10.1186/1745-6215-15-496.
APA
Mansoor, L. E., Abdool Karim, Q., Mngadi, K. T., Dlamini, S., Montague, C., Nkomonde, N., Mvandaba, N., Baxter, C., Gengiah, T. N., Samsunder, N., Dawood, H., Grobler, A., Frohlich, J. A., & Abdool Karim, S. S. (2014). Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial. Trials, 15(1), 360–379. https://doi.org/10.1186/1745-6215-15-496
Chicago
Mansoor, Leila E., Quarraisha Abdool Karim, Kathryn T. Mngadi, Sarah Dlamini, Carl Montague, Nelisiwe Nkomonde, Nomzamo Mvandaba, et al. 2014. “Assessing the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision through Family Planning Services in KwaZulu-Natal, South Africa: Study Protocol for an Open-Label Randomized Controlled Trial.” Trials 15 (1): 360–79. doi:10.1186/1745-6215-15-496.